Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fayette Williams

Dentist, Oral and Maxillofacial Surgery Fort Worth, TX Medical Doctor

NPI 1215130810 CMS profile 145489

1625 Saint Louis Avenue, House Staff & Gme, Fort Worth, TX 76104

Open in the dashboard

General payments

$73,819

164 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Fayette Williams of Fort Worth, TX is reported in the CMS Open Payments database as having received $73,819 across 164 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $36,647 46
2024 General $14,775 26
2023 General $15,654 21
2022 General $3,430 28
2021 General $378 14
2020 General $128 5
2019 General $2,806 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fayette Williams
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Fayette Williams were reported at $36,647. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Fayette Williams Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $2,806 $142 $50–$420 $163
2020 $128 $96 $36–$277 $114
2021 $378 $138 $45–$419 $132
2022 $3,430 $144 $48–$367 $149
2023 $15,654 $153 $55–$399 $160
2024 $14,775 $152 $50–$400 $164
2025 $36,647 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $64,843 73 payments
  2. Synthes GmbH $2,769 3 payments
  3. KLS-Martin L.P. $2,042 11 payments
  4. Nobel Biocare USA $1,860 42 payments
  5. Straumann USA LLC $990 7 payments
  6. Zimmer Biomet Holdings, Inc. $345 6 payments
  7. DePuy Synthes Sales Inc. $186 3 payments
  8. BioHorizons Implant Systems Inc. $168 5 payments
  9. Baxter Healthcare $163 3 payments
  10. AxoGen $153 3 payments
  11. Other $301 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $57,837 23 payments
  2. Travel and Lodging $6,577 20 payments
  3. Food and Beverage $5,281 118 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $2,000 1 payment
  5. Honoraria $1,250 1 payment
  6. Gift $874 1 payment
Products named General payments · program years 2019–2025
  1. NA Craniomaxillofacial $48,688 46 payments
  2. PATIENT-FITTED TMJ RECONSTRUCTIVE PROSTHESIS SYSTEM $18,501 7 payments
  3. NA Craniomaxillofacial $11,206 5 payments
  4. NA Craniomaxillofacial $7,239 12 payments
  5. NA Neuro $1,553 6 payments
  6. NOBELPARALLEL $1,326 15 payments
  7. NOBELACTIVE Dental implant $1,326 15 payments
  8. VSP SYSTEM, VSP CRANIAL $469 2 payments
  9. NOBELACTIVE Dental implant $179 12 payments
  10. NA Craniomaxillofacial $164 2 payments
  11. Other $2,957 66 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

180

Median for Maxillofacial Surgery: 343

Drug cost

$665

Median for Maxillofacial Surgery: $1,437

Branded share of claims

45.6%

Median for Maxillofacial Surgery: 21.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 82 $400
Chlorhexidine Gluconate Generic 49 $184
Amoxicillin Generic 49 $81

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 692 Part D prescribers listed as Maxillofacial Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$14,387

Medicare's payments for the services billed

Medicare patients

57

Average age 67

Services billed

100

31 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 70%
Arthritis 37%
Depression 35%
Diabetes 26%
COPD 26%
Chronic kidney disease 25%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

164 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record